Bayer Taps Roche's Bill Anderson as New CEO; Succession Due in Coming Months
09 February 2023 - 3:59AM
Dow Jones News
By Joshua Kirby
Bayer AG said Wednesday that Chief Executive Officer Werner
Baumann will step down ahead of schedule, to be replaced by Roche
Holding AG executive William N. Anderson from June 1.
Mr. Anderson will join the German conglomerate's board of
management on April 1, becoming CEO over a transition that will end
with Mr. Baumann's retirement at the end of May, Bayer said.
"Werner Baumann will work closely with Bill Anderson to ensure a
smooth transition process," the company said.
Mr. Baumann's contract had originally been set to run until
April next year.
The appointment of Mr. Anderson--currently CEO of Roche
Pharmaceutical--caps a search that began in the middle of last
year, Bayer said.
Shares in Bayer rose 6.2% to EUR62.59 following the news.
Write to Joshua Kirby at joshua.kirby@wsj.com;
@joshualeokirby
(END) Dow Jones Newswires
February 08, 2023 11:44 ET (16:44 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart
From Apr 2023 to Apr 2024
